ID   PKN1_RAT                Reviewed;         946 AA.
AC   Q63433; Q6P748; Q8VIJ2;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   24-JUL-2024, entry version 193.
DE   RecName: Full=Serine/threonine-protein kinase N1;
DE            EC=2.7.11.13 {ECO:0000269|PubMed:8051089};
DE   AltName: Full=Protease-activated kinase 1;
DE            Short=PAK-1;
DE   AltName: Full=Protein kinase C-like 1;
DE   AltName: Full=Protein kinase C-like PKN;
DE   AltName: Full=Protein-kinase C-related kinase 1;
DE   AltName: Full=Serine-threonine protein kinase N;
GN   Name=Pkn1; Synonyms=Pkn, Prk1, Prkcl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=8135837; DOI=10.1006/bbrc.1994.1313;
RA   Mukai H., Ono Y.;
RT   "A novel protein kinase with leucine zipper-like sequences: its catalytic
RT   domain is highly homologous to that of protein kinase C.";
RL   Biochem. Biophys. Res. Commun. 199:897-904(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8943281; DOI=10.1074/jbc.271.50.32233;
RA   Peng B., Morrice N.A., Groenen L.C., Wettenhall R.E.;
RT   "Phosphorylation events associated with different states of activation of a
RT   hepatic cardiolipin/protease-activated protein kinase. Structural identity
RT   to the protein kinase N-type protein kinases.";
RL   J. Biol. Chem. 271:32233-32240(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 633-648; 747-767; 776-822; 880-889 AND 938-946,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=8051089; DOI=10.1016/s0021-9258(17)32124-5;
RA   Morrice N.A., Gabrielli B., Kemp B.E., Wettenhall R.E.;
RT   "A cardiolipin-activated protein kinase from rat liver structurally
RT   distinct from the protein kinases C.";
RL   J. Biol. Chem. 269:20040-20046(1994).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-377.
RX   PubMed=15375078; DOI=10.1096/fj.04-1876fje;
RA   Zhu Y., Stolz D.B., Guo F., Ross M.A., Watkins S.C., Tan B.J., Qi R.Z.,
RA   Manser E., Li Q.T., Bay B.H., Teo T.S., Duan W.;
RT   "Signaling via a novel integral plasma membrane pool of a serine/threonine
RT   protein kinase PRK1 in mammalian cells.";
RL   FASEB J. 18:1722-1724(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-920, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: PKC-related serine/threonine-protein kinase involved in
CC       various processes such as regulation of the intermediate filaments of
CC       the actin cytoskeleton, cell migration, tumor cell invasion and
CC       transcription regulation (PubMed:15375078, PubMed:8051089). Part of a
CC       signaling cascade that begins with the activation of the adrenergic
CC       receptor ADRA1B and leads to the activation of MAPK14 (By similarity).
CC       Regulates the cytoskeletal network by phosphorylating proteins such as
CC       VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit
CC       their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669'
CC       of MAPT/Tau, lowering its ability to bind to microtubules, resulting in
CC       disruption of tubulin assembly. Acts as a key coactivator of androgen
CC       receptor (ANDR)-dependent transcription, by being recruited to ANDR
CC       target genes and specifically mediating phosphorylation of 'Thr-11' of
CC       histone H3 (H3T11ph), a specific tag for epigenetic transcriptional
CC       activation that promotes demethylation of histone H3 'Lys-9' (H3K9me)
CC       by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to
CC       impair their import in the nucleus. Phosphorylates 'Thr-38' of
CC       PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170' of MARCKS, and GFAP. Able
CC       to phosphorylate RPS6 in vitro (By similarity).
CC       {ECO:0000250|UniProtKB:Q16512, ECO:0000269|PubMed:15375078,
CC       ECO:0000269|PubMed:8051089}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC         Evidence={ECO:0000269|PubMed:8051089};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13; Evidence={ECO:0000269|PubMed:8051089};
CC   -!- ACTIVITY REGULATION: Kinase activity is activated upon binding to Rho
CC       proteins (RHOA, RHOB and RAC1). Activated by lipids, particularly
CC       cardiolipin and to a lesser extent by other acidic phospholipids.
CC       Activated by caspase-3 (CASP3) cleavage during apoptosis. Two specific
CC       sites, Thr-778 (activation loop of the kinase domain) and Ser-920 (turn
CC       motif), need to be phosphorylated for its full activation (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with ZFAND6 (By similarity). Interacts with ANDR.
CC       Interacts with PRKCB. Interacts (via REM 1 and REM 2 repeats) with
CC       RAC1. Interacts (via REM 1 repeat) with RHOA. Interacts with RHOB.
CC       Interacts (via C-terminus) with PDPK1. Interacts with CCNT2; enhances
CC       MYOD1-dependent transcription. Component of a signaling complex
CC       containing at least AKAP13, PKN1, MAPK14, ZAK and MAP2K3. Within this
CC       complex, AKAP13 interacts directly with PKN1, which in turn recruits
CC       MAPK14, MAP2K3 and ZAK (By similarity). {ECO:0000250|UniProtKB:P70268,
CC       ECO:0000250|UniProtKB:Q16512}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15375078}. Nucleus
CC       {ECO:0000250|UniProtKB:Q16512}. Endosome
CC       {ECO:0000250|UniProtKB:Q16512}. Cell membrane
CC       {ECO:0000269|PubMed:15375078}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:15375078}. Cleavage furrow
CC       {ECO:0000250|UniProtKB:Q16512}. Midbody {ECO:0000250|UniProtKB:Q16512}.
CC       Note=Associates with chromatin in a ligand-dependent manner (By
CC       similarity). Localization to endosomes is mediated via its interaction
CC       with RHOB. Accumulates during telophase at the cleavage furrow and
CC       finally concentrates around the midbody in cytokinesis (By similarity).
CC       Association to the cell membrane is dependent on Ser-377
CC       phosphorylation. {ECO:0000250|UniProtKB:Q16512,
CC       ECO:0000269|PubMed:15375078}.
CC   -!- DOMAIN: The C1 domain does not bind the diacylglycerol (DAG).
CC       {ECO:0000250}.
CC   -!- PTM: Autophosphorylated; preferably on serine. Phosphorylated during
CC       mitosis. {ECO:0000250|UniProtKB:Q16512}.
CC   -!- PTM: Activated by limited proteolysis with trypsin. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D26180; BAA05168.1; -; mRNA.
DR   EMBL; L35634; AAL31374.1; -; mRNA.
DR   EMBL; BC061836; AAH61836.1; -; mRNA.
DR   PIR; JC2130; JC2130.
DR   RefSeq; NP_058871.2; NM_017175.2.
DR   AlphaFoldDB; Q63433; -.
DR   SMR; Q63433; -.
DR   BioGRID; 248010; 1.
DR   DIP; DIP-60097N; -.
DR   IntAct; Q63433; 9.
DR   STRING; 10116.ENSRNOP00000005770; -.
DR   iPTMnet; Q63433; -.
DR   PhosphoSitePlus; Q63433; -.
DR   jPOST; Q63433; -.
DR   PaxDb; 10116-ENSRNOP00000005770; -.
DR   Ensembl; ENSRNOT00000005770.5; ENSRNOP00000005770.4; ENSRNOG00000004131.7.
DR   Ensembl; ENSRNOT00055012303; ENSRNOP00055009754; ENSRNOG00055007359.
DR   Ensembl; ENSRNOT00060022720; ENSRNOP00060017974; ENSRNOG00060013266.
DR   Ensembl; ENSRNOT00065015702; ENSRNOP00065011871; ENSRNOG00065009743.
DR   GeneID; 29355; -.
DR   KEGG; rno:29355; -.
DR   AGR; RGD:69308; -.
DR   CTD; 5585; -.
DR   RGD; 69308; Pkn1.
DR   eggNOG; KOG0694; Eukaryota.
DR   GeneTree; ENSGT00940000154990; -.
DR   HOGENOM; CLU_000288_132_1_1; -.
DR   InParanoid; Q63433; -.
DR   OrthoDB; 5400441at2759; -.
DR   BRENDA; 2.7.11.13; 5301.
DR   Reactome; R-RNO-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-RNO-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013026; RHOB GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   PRO; PR:Q63433; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000004131; Expressed in spleen and 19 other cell types or tissues.
DR   GO; GO:0032154; C:cleavage furrow; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; ISS:UniProtKB.
DR   GO; GO:0035402; F:histone H3T11 kinase activity; ISS:UniProtKB.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; ISS:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; ISS:UniProtKB.
DR   GO; GO:0001783; P:B cell apoptotic process; ISO:RGD.
DR   GO; GO:0001782; P:B cell homeostasis; ISO:RGD.
DR   GO; GO:0010631; P:epithelial cell migration; ISS:UniProtKB.
DR   GO; GO:0006972; P:hyperosmotic response; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0043687; P:post-translational protein modification; ISS:UniProtKB.
DR   GO; GO:2000145; P:regulation of cell motility; ISS:UniProtKB.
DR   GO; GO:0002634; P:regulation of germinal center formation; ISO:RGD.
DR   GO; GO:0002637; P:regulation of immunoglobulin production; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0003014; P:renal system process; ISO:RGD.
DR   GO; GO:0048536; P:spleen development; ISO:RGD.
DR   CDD; cd08687; C2_PKN-like; 1.
DR   CDD; cd11630; HR1_PKN1_2; 1.
DR   CDD; cd11622; HR1_PKN_1; 1.
DR   CDD; cd05589; STKc_PKN; 1.
DR   Gene3D; 1.10.287.160; HR1 repeat; 3.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR037784; C2_PKN.
DR   InterPro; IPR011072; HR1_rho-bd.
DR   InterPro; IPR036274; HR1_rpt_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR037317; PKN1_HR1_2.
DR   InterPro; IPR037313; PKN_HR1_1.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050236; Ser_Thr_kinase_AGC.
DR   PANTHER; PTHR24356; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24356:SF246; SERINE_THREONINE-PROTEIN KINASE N1; 1.
DR   Pfam; PF02185; HR1; 3.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00742; Hr1; 3.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF46585; HR1 repeat; 3.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS51860; REM_1; 3.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell membrane; Chromatin regulator; Coiled coil;
KW   Cytoplasm; Direct protein sequencing; Endosome; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   CHAIN           2..946
FT                   /note="Serine/threonine-protein kinase N1"
FT                   /id="PRO_0000055721"
FT   DOMAIN          25..100
FT                   /note="REM-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          114..193
FT                   /note="REM-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          202..283
FT                   /note="REM-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          310..473
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          619..878
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          879..946
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   REGION          345..387
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          556..607
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          906..925
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        558..602
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        744
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         625..633
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         648
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            108..109
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   SITE            457..458
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   SITE            561..562
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         69
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15375078"
FT   MOD_RES         451
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         536
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         540
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         543
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         565
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         612
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         778
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         782
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         918
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16512"
FT   MOD_RES         920
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        298
FT                   /note="A -> R (in Ref. 2; AAL31374)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        510
FT                   /note="Q -> H (in Ref. 1; BAA05168)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        650
FT                   /note="L -> V (in Ref. 2; AAL31374)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        722
FT                   /note="V -> G (in Ref. 1; BAA05168)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        808
FT                   /note="L -> F (in Ref. 1; BAA05168)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   946 AA;  104468 MW;  63DF250C8D2DA444 CRC64;
     MAGDAVQSEP RSWSLLEQLG LAGADLAAPG VQQQLELERE RLKREIRKEL KLKEGAENLR
     RATTDLGRSL APVELLLRGS ARRLDLLHQQ LQELHAHVVL PDPTAGSDAP QSLAEGSPVC
     SSTNLSRVAG LEKQLAIELK VKQGAENMIQ TYSNGSTKDR KLLLTAQQML QDSKTKIDII
     RMQLRRALQA LQAGQLESQA APDEAHGDPD LGAVELRIEE LRHHFRVEHA VAEGAKNVLR
     LLSAAKAPDR KAVSEAQEKL TESNQKLGLL RESLERRLGE LPADHPKGRL LREELTAASS
     AAFSAILPGP FPATHYSTLS KPAPLTGTLE VRVVGCKNLP ETIPWSPPPS VGASGTPDSR
     TPFLSRPARG LYNRSGSLSG RSSLKGEAEN STEVSTVLKL DNTVVGQTAW KPCGPNAWDQ
     SFTLELERAR ELELAVFWRD QRGLCALKFL KLEDFLDNER HEVQLDMEPQ GCLVAEVTFR
     NPIIERIPRL QRQKKIFSKQ QGQTFQRARQ MNIDVATWVR LLRRLIPNAV ATGSFSPNAS
     PGSEIRSTGD ISMEKLNLGA DSDSSSQKSP AGLPSTSCSL SSPTHESTTS PELPSETQET
     PGPGLCSPLR KSPLTLEDFK FLAVLGRGHF GKVLLSEFHS SGELFAIKAL KKGDIVARDE
     VESLMCEKRI LATVTRAGHP FLVNLFGCFQ TPEHVCFVME YSAGGDLMLH IHSDVFSEPR
     AVFYSACVVL GLQFLHEHKI VYRDLKLDNL LLDTEGYVKI ADFGLCKEGM GYGDRTSTFC
     GTPEFLAPEV LTDTSYTRAV DWWGLGVLLY EMLVGESPFP GDDEEEVFDS IVNDEVRYPR
     FLSAEAIGIM RRLLRRNPER RLGSTERDAE DVKKQPFFRT LDWDALLARR LPPPFVPTLS
     GRTDVSNFDE EFTGEAPTLS PPRDARPLTA AEQAAFRDFD FVAGGY
//
